1. Home
  2. KTB vs IOVA Comparison

KTB vs IOVA Comparison

Compare KTB & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kontoor Brands Inc.

KTB

Kontoor Brands Inc.

HOLD

Current Price

$67.24

Market Cap

3.8B

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.05

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTB
IOVA
Founded
2018
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
2.1B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
KTB
IOVA
Price
$67.24
$4.05
Analyst Decision
Strong Buy
Buy
Analyst Count
9
10
Target Price
$99.67
$9.11
AVG Volume (30 Days)
945.5K
18.2M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
3.14%
N/A
EPS Growth
N/A
14.84
EPS
4.05
N/A
Revenue
$2,097,839,000.00
N/A
Revenue This Year
$10.42
$49.14
Revenue Next Year
$3.62
$51.69
P/E Ratio
$16.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.00
$1.64
52 Week High
$87.00
$5.63

Technical Indicators

Market Signals
Indicator
KTB
IOVA
Relative Strength Index (RSI) 47.83 54.36
Support Level $63.04 $1.99
Resistance Level $72.31 $4.34
Average True Range (ATR) 3.28 0.47
MACD -0.82 -0.05
Stochastic Oscillator 28.15 24.18

Price Performance

Historical Comparison
KTB
IOVA

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It designs, manufactures, procures, sells, and licenses apparel, footwear, and accessories, mainly under the brand names Wrangler, Lee, Helly Hansen, and a few other brands. The company also licenses the use of its brands in certain regions. Its products are sold through wholesale and direct-to-consumer channels in the United States (its key revenue-generating market) and internationally, mainly in Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Non-U.S. Americas regions. The company's three reportable segments are Wrangler, Lee, and Helly Hansen. The majority of its revenue is generated from the Wrangler segment, which offers denim, apparel, footwear, and accessories through Wrangler and various sub-brands.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: